Disease on EC 3.4.24.3 - microbial collagenase
Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Adenocarcinoma
[New direct assay method of type IV collagenase in tissue homogenate and biochemical role of collagenase against type I, and IV collagens to the invasion of the stomach and lung cancer]
Anthrax
Inhibition of bacterial carbonic anhydrases and zinc proteases: from orphan targets to innovative new antibiotic drugs.
Anti-Glomerular Basement Membrane Disease
Heterogeneity of antibodies in Goodpasture syndrome reacting with type IV collagen.
Arthritis
Decrease in expression of bone morphogenetic proteins 4 and 5 in synovial tissue of patients with osteoarthritis and rheumatoid arthritis.
Arthritis, Rheumatoid
[Detection of collagenase in passive haemagglutination using collagen-coated erythrocytes (author's transl)]
Bone Resorption
H-31 human breast cancer cells stimulate type I collagenase production in osteoblast-like cells and induce bone resorption.
Brain Edema
Metalloproteinase inhibition blocks edema in intracerebral hemorrhage in the rat.
Brain Edema
Modeling intracerebral hemorrhage in mice: injection of autologous blood or bacterial collagenase.
Brain Injuries
Cannabinoid CB2 receptor stimulation attenuates brain edema and neurological deficits in a germinal matrix hemorrhage rat model.
Breast Neoplasms
H-31 human breast cancer cells stimulate type I collagenase production in osteoblast-like cells and induce bone resorption.
Bursitis
Clostridium histolyticum (AA4500) for the Treatment of Adhesive Capsulitis of the Shoulder: A Randomised Double-Blind, Placebo-Controlled Study for the Safety and Efficacy of Collagenase - Single Site Report.
Bursitis
CORR(®) ORS Richard A. Brand Award: Clinical Trials of a New Treatment Method for Adhesive Capsulitis.
Carcinoma
Collagenase-1 injection improved tumor distribution and gene expression of cationic lipoplex.
Carcinoma
Detection of mRNAs encoding collagenase I and stromelysin 2 in carcinomas of the head and neck by in situ hybridization.
Carcinoma
Increased stromelysin 3 gene expression is associated with increased local invasiveness in head and neck squamous cell carcinomas.
Carcinoma
[New direct assay method of type IV collagenase in tissue homogenate and biochemical role of collagenase against type I, and IV collagens to the invasion of the stomach and lung cancer]
Carcinoma, Papillary
[Study of type I and IV collagenase activity in human thyroid diseases]
Carcinoma, Squamous Cell
[New direct assay method of type IV collagenase in tissue homogenate and biochemical role of collagenase against type I, and IV collagens to the invasion of the stomach and lung cancer]
Cerebral Hemorrhage
Effect of fucoidan treatment on collagenase-induced intracerebral hemorrhage in rats.
Cerebral Hemorrhage
Enhanced pulmonary inflammation following experimental intracerebral hemorrhage.
Cerebral Hemorrhage
Experimental intracerebral hemorrhage in rats. Magnetic resonance imaging and histopathological correlates.
Cerebral Hemorrhage
Intrastriatal injection of autologous blood or clostridial collagenase as murine models of intracerebral hemorrhage.
Cerebral Hemorrhage
Metalloproteinase inhibition blocks edema in intracerebral hemorrhage in the rat.
Cerebral Hemorrhage
Modeling intracerebral hemorrhage in mice: injection of autologous blood or bacterial collagenase.
Cerebral Hemorrhage
Pharmacogenomic effects of apolipoprotein e on intracerebral hemorrhage.
Cerebral Hemorrhage
Protective effects of free radical inhibitors in intracerebral hemorrhage in rat.
Cerebral Hemorrhage
Rapid Loss of Perihematomal Cell Viability in the Collagenase Intracerebral Hemorrhage Model.
Cerebral Hemorrhage
Sheng-Di-Da-Huang Decoction Inhibited Inflammation Expressed in Microglia after Intracerebral Hemorrhage in Rats.
Cerebral Hemorrhage
Simultaneous detection and separation of hyperacute intracerebral hemorrhage and cerebral ischemia using amide proton transfer MRI.
Cerebral Hemorrhage
Therapeutic benefit of human umbilical cord derived mesenchymal stromal cells in intracerebral hemorrhage rat: implications of anti-inflammation and angiogenesis.
Cerebral Palsy
Intramuscular injection of collagenase clostridium histolyticum may decrease spastic muscle contracture for children with cerebral palsy.
Chondrosarcoma
Partial characterization of procollagen messenger ribonucleic acid in a murine chondrosarcoma.
Colorectal Neoplasms
Imaging intratumoral convection: pressure-dependent enhancement in chemotherapeutic delivery to solid tumors.
Congenital Abnormalities
At what cost is collagenase clostridium histolyticum viable for treating Peyronie's disease in a public healthcare system?
Congenital Abnormalities
Collagenase clostridium histolyticum for the treatment of Peyronie's disease: a prospective Italian multicentric study.
Congenital Abnormalities
Collagenase clostridium histolyticum: a novel medical treatment for Peyronie's disease.
Congenital Abnormalities
Collagenase Treatment of Dupuytren's Disease with Minimum 5-Year Follow-Up: Recurrence, Reintervention, and Satisfaction.
Congenital Abnormalities
Collagenase versus placebo in the treatment of Peyronie's disease: a double-blind study.
Congenital Abnormalities
Factors Associated With Erectile Dysfunction and the Peyronie's Disease Questionnaire in Patients With Peyronie Disease.
Congenital Abnormalities
How Atypical Penile Curvature Influence Clinical Outcomes in Patients with Peyronie's Disease Receiving Collagenase Clostridium Histolyticum Therapy?
Congenital Abnormalities
Long-term Curvature Deformity Characterization in Men Previously Treated With Collagenase Clostridium Histolyticum for Peyronie's Disease, Subgrouped by Penile Plaque Calcification.
Congenital Abnormalities
Long-Term Safety and Curvature Deformity Characterization in Patients Previously Treated with Collagenase Clostridium Histolyticum for Peyronie's Disease.
Congenital Abnormalities
Minimally Invasive Treatment of Peyronie's Disease: Evidence-Based Progress.
Congenital Abnormalities
Review of Management Options for Patients With Atypical Peyronie's Disease.
Congenital Abnormalities
Safety Profile of Collagenase Clostridium Histolyticum Stratified by Degree of Penile Curvature in Patients With Peyronie Disease.
Congenital Abnormalities
Surgical correction of persistent Peyronie's disease following collagenase clostridium histolyticum treatment.
Congenital Abnormalities
The Influence of Indentation Deformity on Outcomes With Intralesional Collagenase Clostridium Histolyticum Monotherapy for Peyronie's Disease.
Congenital Abnormalities
Treatment of Peyronie's Disease With Collagenase Clostridium histolyticum and Vacuum Therapy: A Randomized, Open-Label Pilot Study.
Congenital Abnormalities
Treatment-related Outcomes for Patients With Atypical Peyronie's Disease Using Xiaflex Injections.
Contracture
Acute double flexor tendon ruptures following injection of collagenase clostridium histolyticum (Xiapex) for Dupuytren's contracture.
Contracture
Analysis of Efficacy and Safety of Treatment With Collagenase Clostridium histolyticum Among Subgroups of Patients With Dupuytren Contracture.
Contracture
Collagenase Clostridium histolyticum for the Treatment of Distal Interphalangeal Joint Contractures in Dupuytren Disease.
Contracture
Collagenase clostridium histolyticum in Dupuytren's contracture: a systematic review.
Contracture
Collagenase Clostridium Histolyticum Injection for Dupuytren Contracture: 2-Year Follow-up.
Contracture
Collagenase Clostridium Histolyticum versus Limited Fasciectomy for Dupuytren's Contracture: Outcomes from a Multicenter Propensity Score Matched Study.
Contracture
Collagenase Clostridium histolyticum. Short-term benefit in Dupuytren's contracture, unknown long-term risks.
Contracture
Collagenase Treatment of Dupuytren's Disease with Minimum 5-Year Follow-Up: Recurrence, Reintervention, and Satisfaction.
Contracture
Current role of the collagenase Clostridium histolyticum in Dupuytren's disease treatment.
Contracture
Determining clinically important changes in range of motion in patients with Dupuytren's Contracture: secondary analysis of the randomized, double-blind, placebo-controlled CORD I study.
Contracture
Durability of Collagenase Treatment for Dupuytren Disease of the Thumb and First Web After at Least 2 Years' Follow-Up.
Contracture
Efficacy and safety of collagenase clostridium histolyticum in the treatment of proximal interphalangeal joints in dupuytren contracture: combined analysis of 4 phase 3 clinical trials.
Contracture
Efficacy and safety of concurrent collagenase clostridium histolyticum injections for multiple Dupuytren contractures.
Contracture
Examining the efficacy and maintenance of contracture correction after collagenase clostridium histolyticum treatment for Dupuytren's disease.
Contracture
Hand function 5 years after treatment with collagenase Clostridium histolyticum injection for Dupuytren's disease.
Contracture
In Vitro Study of Novel Collagenase (XIAFLEX®) on Dupuytren's Disease Fibroblasts Displays Unique Drug Related Properties.
Contracture
Intramuscular injection of collagenase clostridium histolyticum may decrease spastic muscle contracture for children with cerebral palsy.
Contracture
Isolated and Spontaneous Correction of Proximal Interphalangeal Joint Contractures in Dupuytren's Disease: An Exploratory Analysis of the Efficacy and Safety of Collagenase Clostridium histolyticum.
Contracture
Late Complications of Clinical Clostridium Histolyticum Collagenase Use in Dupuytren's Disease.
Contracture
Letter Regarding "Dupuytren Contracture Recurrence Following Treatment With Collagenase Clostridium Histolyticum (CORDLESS [Collagenase Option for Reduction of Dupuytren Long-Term Evaluation of Safety Study]): 5-Year Data".
Contracture
Morphological patterns of the pretendinous cord in Dupuytren's disease: a predictor of clinical outcome?
Contracture
Multiple Recurrences in Aggressive Forms of Dupuytren's Disease-Can Patients Benefit from Repeated Selective Fasciectomy?
Contracture
Needle fasciotomy for Dupuytren's contracture- a prospective cohort study of 58 fingers with a median follow-up of 6.5 years.
Contracture
One year follow-up after treatment with CCH for Dupuytren's disease: A prospective view.
Contracture
Outcome of Dupuytren Contractures After Collagenase Clostridium Histolyticum Injection: A Single-institution Experience.
Contracture
Outcome of Dupuytren's Contractures After Collagenase Clostridium Histolyticum Injection: A Single Institution Experience.
Contracture
Percutaneous Needle Fasciotomy Versus Collagenase Treatment for Dupuytren Contracture: A Randomized Controlled Trial with a Two-Year Follow-up.
Contracture
Risk Factors for Skin Tearing in Collagenase Treatment of Dupuytren Contractures.
Contracture
Risk Factors for Skin Tears Following Collagenase Clostridium histolyticum to Treat Dupuytren Contractures.
Contracture
Skin Laceration in Collagenase Clostridium histolyticum Treatment for Dupuytren's Contracture.
Contracture
The efficacies and limitations of fasciectomy and collagenase clostridium histolyticum in Dupuytren's contracture management: A meta-analysis.
Contracture
The Efficacy and Safety of Concurrent Collagenase Clostridium Histolyticum Injections for 2 Dupuytren Contractures in the Same Hand: A Prospective, Multicenter Study.
Contracture
[Collagenase clostridum histolyticum in the management of Dupuytren's contracture].
Dermatitis
Toxic dermatitis secondary to treatment with collagenase clostridium histolyticum for Dupuytren´s disease.
Dermatitis, Contact
Contact dermatitis with clostridiopeptidase A contained in Noruxol ointment.
Diabetes Mellitus
Clinical outcomes associated with serial sharp debridement of diabetic foot ulcers with and without clostridial collagenase ointment.
Diabetes Mellitus
Enzymatic Debridement of Chronic Nonischemic Diabetic Foot Ulcers: Results of a Randomized, Controlled Trial.
Diabetes Mellitus, Type 2
Enzymatic Debridement of Chronic Nonischemic Diabetic Foot Ulcers: Results of a Randomized, Controlled Trial.
Diabetic Foot
Clinical outcomes associated with serial sharp debridement of diabetic foot ulcers with and without clostridial collagenase ointment.
Diabetic Foot
Clinical Outcomes for Diabetic Foot Ulcers Treated with Clostridial Collagenase Ointment or with a Product Containing Silver.
Diabetic Foot
Clostridial Collagenase for the Management of Diabetic Foot Ulcers: Results of Four Randomized Controlled Trials.
Diabetic Foot
Cost-effectiveness of clostridial collagenase ointment on wound closure in patients with diabetic foot ulcers: economic analysis of results from a multicenter, randomized, open-label trial.
Diabetic Foot
Enzymatic Debridement of Chronic Nonischemic Diabetic Foot Ulcers: Results of a Randomized, Controlled Trial.
Diabetic Foot
Erratum to: Cost-effectiveness of clostridial collagenase ointment on wound closure in patients with diabetic foot ulcers: economic analysis of results from a multicenter, randomized, open-label trial.
Diabetic Foot
Health Care Spending in Patients With Stage 3 and Stage 4 Pressure Injuries and Patients With Diabetic Foot Ulcers Treated Early With Clostridial Collagenase Ointment: A Retrospective Data Review.
Diabetic Retinopathy
Enzyme-assisted vitrectomy with bacterial collagenase. Pilot human studies.
Dupuytren Contracture
"Collagenase Clostridium Histolyticum for Dupuytren Contracture: Comparing Single and Concurrent Injections."
Dupuytren Contracture
A post hoc analysis of Dupuytren contracture treated with collagenase Clostridium histolyticum across disease stages.
Dupuytren Contracture
A single injection of collagenase clostridium histolyticum for the treatment of moderate Dupuytren's contracture: a 2?year follow-up of 47 patients.
Dupuytren Contracture
Acute double flexor tendon ruptures following injection of collagenase clostridium histolyticum (Xiapex) for Dupuytren's contracture.
Dupuytren Contracture
Adverse effects associated with collagenase clostridium histolyticum in Dupuytren disease: A prospective study.
Dupuytren Contracture
Adverse Effects of Collagenase in the Treatment of Dupuytren Disease: A Systematic Review.
Dupuytren Contracture
Analysis of Efficacy and Safety of Treatment With Collagenase Clostridium histolyticum Among Subgroups of Patients With Dupuytren Contracture.
Dupuytren Contracture
Anesthesia for collagenase clostridium histolyticum injection in patients with dupuytren disease: A cohort analysis.
Dupuytren Contracture
Assessing Potential Cross-Reactivity of Human Endogenous Matrix Metalloproteinases (MMPs) with Collagenase Clostridium Histolyticum (CCH) Antibodies in Human Serum for Patients with Dupuytren's Contracture.
Dupuytren Contracture
Budget impact analysis in Spanish patients with Dupuytren's contracture: Fasciectomy vs. collagenase Clostridium histolyticum.
Dupuytren Contracture
Can collagenase effectiveness in Dupuytren's contracture be improved by using ultrasound-guided Injection? A comparative study.
Dupuytren Contracture
Changes in Provider Treatment Patterns for Dupuytren's Contracture: Analysis of Trends in Medicare Beneficiaries.
Dupuytren Contracture
Clostridium histolyticum collagenase in the treatment of Dupuytren's contracture.
Dupuytren Contracture
Cold Intolerance Following Collagenase Clostridium histolyticum Treatment for Dupuytren Contracture.
Dupuytren Contracture
Cold intolerance following collagenase Clostridium histolyticum treatment for Dupuytren contracture: a molecular mechanism.
Dupuytren Contracture
Collagenase clostridium histolyticum for dupuytren contracture: patterns of use and effectiveness in clinical practice.
Dupuytren Contracture
Collagenase Clostridium histolyticum for the Treatment of Distal Interphalangeal Joint Contractures in Dupuytren Disease.
Dupuytren Contracture
Collagenase clostridium histolyticum for the treatment of Dupuytren's contracture: systematic review and economic evaluation.
Dupuytren Contracture
Collagenase clostridium histolyticum in Dupuytren's contracture: a systematic review.
Dupuytren Contracture
Collagenase Clostridium histolyticum in patients with Dupuytren's contracture: results from POINT X, an open-label study of clinical and patient-reported outcomes.
Dupuytren Contracture
Collagenase Clostridium Histolyticum Injection for Dupuytren Contracture: 2-Year Follow-up.
Dupuytren Contracture
Collagenase clostridium histolyticum injection for the treatment of Dupuytren's contracture.
Dupuytren Contracture
Collagenase Clostridium histolyticum Injection Therapy Improves Health-related Quality of Life in Patients with Dupuytren's Disease.
Dupuytren Contracture
Collagenase Clostridium Histolyticum Injection with Precise Needle Length Adjusted by Silicone Tube Interposition for Dupuytren Contracture.
Dupuytren Contracture
Collagenase Clostridium Histolyticum versus Limited Fasciectomy for Dupuytren's Contracture: Outcomes from a Multicenter Propensity Score Matched Study.
Dupuytren Contracture
Collagenase Clostridium histolyticum. Short-term benefit in Dupuytren's contracture, unknown long-term risks.
Dupuytren Contracture
Collagenase Treatment for Dupuytren Disease of the Thumb and First Web.
Dupuytren Contracture
Collagenase treatment of Dupuytren's contracture using a modified injection method.
Dupuytren Contracture
Collagenase Treatment of Dupuytren's Disease with Minimum 5-Year Follow-Up: Recurrence, Reintervention, and Satisfaction.
Dupuytren Contracture
Comparison of Treatment Outcomes after Collagenase Injection and Percutaneous Needle Fasciotomy for Dupuytren's Contracture: Objective and Subjective Comparisons with a 3-Year Follow-Up.
Dupuytren Contracture
Complications Following Collagenase Treatment for Dupuytren Contracture.
Dupuytren Contracture
Cost Comparison of Collagenase Clostridium Histolyticum and Fasciectomy for Treatment of Dupuytren's Contracture in the Australian Health System.
Dupuytren Contracture
Current role of the collagenase Clostridium histolyticum in Dupuytren's disease treatment.
Dupuytren Contracture
Delayed manipulation after collagenase clostridium histolyticum injection for Dupuytren contracture.
Dupuytren Contracture
Determining clinically important changes in range of motion in patients with Dupuytren's Contracture: secondary analysis of the randomized, double-blind, placebo-controlled CORD I study.
Dupuytren Contracture
Discussion: Collagenase Clostridium Histolyticum for Dupuytren Contracture: Comparing Single and Concurrent Injections.
Dupuytren Contracture
Does collagenase injection disrupt or digest the Dupuytren's cord: a magnetic resonance imaging study.
Dupuytren Contracture
Dupuytren contracture recurrence following treatment with collagenase clostridium histolyticum (CORDLESS study): 3-year data.
Dupuytren Contracture
Dupuytren Contracture Recurrence Following Treatment With Collagenase Clostridium histolyticum (CORDLESS [Collagenase Option for Reduction of Dupuytren Long-Term Evaluation of Safety Study]): 5-Year Data.
Dupuytren Contracture
DupuytrEn Treatment EffeCtiveness Trial (DETECT): a protocol for prospective, randomised, controlled, outcome assessor-blinded, three-armed parallel 1:1:1, multicentre trial comparing the effectiveness and cost of collagenase clostridium histolyticum, percutaneous needle fasciotomy and limited fasciectomy as short-term and long-term treatment strategies in Dupuytren's contracture.
Dupuytren Contracture
Durability of Collagenase Treatment for Dupuytren Disease of the Thumb and First Web After at Least 2 Years' Follow-Up.
Dupuytren Contracture
Early outcomes of a sequential series of 144 patients with Dupuytren's contracture treated by collagenase injection using an increased dose, multi-cord technique.
Dupuytren Contracture
Efficacy and adverse effects of collagenase use in the treatment of Dupuytren's disease: a meta-analysis.
Dupuytren Contracture
Efficacy and safety of collagenase clostridium histolyticum for Dupuytren disease nodules: a randomized controlled trial.
Dupuytren Contracture
Efficacy and safety of collagenase clostridium histolyticum in the treatment of proximal interphalangeal joints in dupuytren contracture: combined analysis of 4 phase 3 clinical trials.
Dupuytren Contracture
Efficacy and safety of collagenase Clostridium histolyticum injection for Dupuytren contracture: report of 40 cases.
Dupuytren Contracture
Efficacy and safety of collagenase clostridium histolyticum injection for Dupuytren contracture: short-term results from 2 open-label studies.
Dupuytren Contracture
Efficacy and safety of collagenase Clostridium histolyticum injection for Dupuytren's contracture in non-Caucasian Japanese patients (CORD-J Study): the first clinical trial in a non-Caucasian population.
Dupuytren Contracture
Efficacy and safety of collagenase treatment for Dupuytren's disease: 2-year follow-up results.
Dupuytren Contracture
Efficacy of collagenase Clostridium histolyticum injection for Dupuytren's contracture in East-Asian population.
Dupuytren Contracture
Efficacy of collagenase in patients who did and did not have previous hand surgery for Dupuytren's contracture.
Dupuytren Contracture
Erratum: Healthcare Costs and Resource Use of Patients with Dupuytren Contracture Treated with Collagenase Clostridium Histolyticum or Fasciectomy: A Propensity Matching Analysis [Corrigendum].
Dupuytren Contracture
Examining the efficacy and maintenance of contracture correction after collagenase clostridium histolyticum treatment for Dupuytren's disease.
Dupuytren Contracture
Functional outcome of collagenase injections compared with fasciectomy in treatment of Dupuytren's contracture.
Dupuytren Contracture
Hand function 5 years after treatment with collagenase Clostridium histolyticum injection for Dupuytren's disease.
Dupuytren Contracture
Healthcare Costs and Resource Use of Patients with Dupuytren Contracture Treated with Collagenase Clostridium Histolyticum or Fasciectomy: A Propensity Matching Analysis.
Dupuytren Contracture
Injectable collagenase Clostridium histolyticum as a nonsurgical treatment for Dupuytren's disease.
Dupuytren Contracture
Injectable collagenase clostridium histolyticum for Dupuytren's contracture.
Dupuytren Contracture
Injectable collagenase Clostridium histolyticum: a new nonsurgical treatment for Dupuytren's disease.
Dupuytren Contracture
Injectable Collagenase Versus Percutaneous Needle Fasciotomy for Dupuytren Contracture in Proximal Interphalangeal Joints: A Randomized Controlled Trial.
Dupuytren Contracture
Isolated and Spontaneous Correction of Proximal Interphalangeal Joint Contractures in Dupuytren's Disease: An Exploratory Analysis of the Efficacy and Safety of Collagenase Clostridium histolyticum.
Dupuytren Contracture
Late Complications of Clinical Clostridium Histolyticum Collagenase Use in Dupuytren's Disease.
Dupuytren Contracture
Limited Fasciectomy Versus Collagenase Clostridium histolyticum for Dupuytren Contracture: A Propensity Score Matched Study of Single Digit Treatment With Minimum 5 Years of Telephone Follow-Up.
Dupuytren Contracture
Measurement properties of the German Unité Rhumatologique des Affections de la Main (URAM) scale in patients treated for Dupuytren's disease.
Dupuytren Contracture
Needle fasciotomy for Dupuytren's contracture- a prospective cohort study of 58 fingers with a median follow-up of 6.5 years.
Dupuytren Contracture
New insights into the immediate outcome of collagenase injections for Dupuytren's contracture.
Dupuytren Contracture
Nonsurgical treatment of Dupuytren's contracture: 1-year US post-marketing safety data for collagenase clostridium histolyticum.
Dupuytren Contracture
Outcome of Dupuytren Contractures After Collagenase Clostridium Histolyticum Injection: A Single-institution Experience.
Dupuytren Contracture
Outcomes and Early Recurrence Following Enzymatic (Collagenase) Treatment of Moderate and Severe Dupuytren Contractures.
Dupuytren Contracture
Pain Associated With Treatment of Dupuytren Contracture With Collagenase Clostridium histolyticum.
Dupuytren Contracture
Percutaneous Needle Fasciotomy versus Collagenase Injection for Dupuytren's Contracture: A Systematic Review of Comparative Studies.
Dupuytren Contracture
Percutaneous Needle Fasciotomy Versus Collagenase Treatment for Dupuytren Contracture: A Randomized Controlled Trial with a Two-Year Follow-up.
Dupuytren Contracture
Phalangeal fracture leading to digital amputation, sustained during manipulation for Dupuytren's disease as part of clostridial collagenase treatment.
Dupuytren Contracture
Postapproval clinical experience in the treatment of Dupuytren's contracture with collagenase clostridium histolyticum (CCH): the first 1,000 days.
Dupuytren Contracture
Prospective observation of Clostridium histolyticum collagenase for the treatment of Dupuytren's disease in 788 patients: the Austrian register.
Dupuytren Contracture
Prospective randomized controlled trial comparing 1- versus 7-day manipulation following collagenase injection for dupuytren contracture.
Dupuytren Contracture
Range of motion, postoperative rehabilitation and patient satisfaction in MCP and PIP joints affected by Dupuytren Tubiana stage 1-3: collagenase enzymatic fasciotomy or limited fasciectomy? A clinical study in 52 patients.
Dupuytren Contracture
Recurrent Dupuytren's disease after fasciectomy and collagenase injection are histologically indistinguishable.
Dupuytren Contracture
Resource utilisation associated with single digit Dupuytren's contracture treated with either surgery or injection of collagenase Clostridium histolyticum.
Dupuytren Contracture
Retraction: Late complications of clinical Clostridium histolyticum collagenase use in Dupuytren's disease.
Dupuytren Contracture
Return-to-Function Following Treatment of Dupuytren Contracture With Collagenase Clostridium Histolyticum Versus Fasciectomy.
Dupuytren Contracture
Safety and tolerability of collagenase Clostridium histolyticum and fasciectomy for Dupuytren's contracture.
Dupuytren Contracture
Salvage palmar fasciectomy after initial treatment with collagenase clostridium histolyticum.
Dupuytren Contracture
Seven-year clinical outcomes after collagenase injection in patients with Dupuytren's disease: A prospective study.
Dupuytren Contracture
Short-term efficacy and safety of collagenase injection for Dupuytren's contracture: Therapy protocol for successful outcomes in a clinical setting.
Dupuytren Contracture
Skin graft loss resulting from collagenase clostridium histolyticum treatment of dupuytren contracture: case report and review of the literature.
Dupuytren Contracture
Skin Laceration in Collagenase Clostridium histolyticum Treatment for Dupuytren's Contracture.
Dupuytren Contracture
Surgical findings in the treatment of Dupuytren's disease after initial treatment with clostridial collagenase (Xiaflex).
Dupuytren Contracture
The Effects of Collagenase Clostridium histolyticum on Plantar Fibromatosis: A Case Study.
Dupuytren Contracture
The efficacies and limitations of fasciectomy and collagenase clostridium histolyticum in Dupuytren's contracture management: A meta-analysis.
Dupuytren Contracture
The efficacy and safety of collagenase clostridium histolyticum in the treatment of patients with moderate Dupuytren's contracture.
Dupuytren Contracture
The emerging role of Clostridium histolyticum collagenase in the treatment of Dupuytren disease.
Dupuytren Contracture
The influence of skin tears following collagenase treatment of Dupuytren's disease on treatment outcomes.
Dupuytren Contracture
The use of Collagenase Clostridium Histolyticum in the management of Dupuytren's contracture-outcomes of a pilot study in a District General Hospital setting.
Dupuytren Contracture
Toxic dermatitis secondary to treatment with collagenase clostridium histolyticum for Dupuytren´s disease.
Dupuytren Contracture
Treatment of dupuytren disease with injectable collagenase in a veteran population: a case series at the department of veterans affairs new jersey health care system.
Dupuytren Contracture
Treatment of Dupuytren's Contracture With Collagenase: A Systematic Review.
Dupuytren Contracture
Treatment of Recurrent Dupuytren Contracture in Joints Previously Effectively Treated With Collagenase Clostridium histolyticum.
Dupuytren Contracture
Use of resources and costs associated with the treatment of Dupuytren's contracture at an orthopedics and traumatology surgery department in Denia (Spain): collagenase clostridium hystolyticum versus subtotal fasciectomy.
Dupuytren Contracture
What is the better treatment for single digit dupuytren's contracture: surgical release or collagenase clostridium histolyticum (Xiapex) injection?
Dupuytren Contracture
[Collagenase clostridum histolyticum in the management of Dupuytren's contracture].
Dupuytren Contracture
[Comparative Cost Effectiveness of Clostridium Histolyticum Collagenase (Xiapex®) and Partial Fasciectomy for the Treatment of Dupuytren's Contracture in Austria].
Dupuytren Contracture
[Long-term experience with Collagenase Clostridium Histolyticum (CCH, Xiapex®) for the treatment of Dupuytren's contracture: lessons learned].
Dupuytren Contracture
[Treatment of Dupuytren's disease with collagenase Clostridium histolyticum].
Epidermolysis Bullosa Acquisita
Epidermolysis bullosa acquisita antigen: relationship between the collagenase-sensitive and -insensitive domains.
Epidermolysis Bullosa Dystrophica
Inhibition of collagenase type I expression by psoralen antisense oligonucleotides in dermal fibroblasts.
Erectile Dysfunction
The 32nd Annual J.P. Morgan Healthcare Conference (January 13-16, 2014 - San Francisco, California, USA): Auxilium Pharmaceuticals.
Exanthema
Toxic dermatitis secondary to treatment with collagenase clostridium histolyticum for Dupuytren´s disease.
Fibromatosis, Plantar
Collagenase Clostridium histolyticum injection for plantar fibromatosis (Ledderhose disease).
Fibromatosis, Plantar
The Effects of Collagenase Clostridium histolyticum on Plantar Fibromatosis: A Case Study.
Foot Ulcer
Clinical outcomes associated with serial sharp debridement of diabetic foot ulcers with and without clostridial collagenase ointment.
Foot Ulcer
Clinical Outcomes for Diabetic Foot Ulcers Treated with Clostridial Collagenase Ointment or with a Product Containing Silver.
Foot Ulcer
Clostridial Collagenase for the Management of Diabetic Foot Ulcers: Results of Four Randomized Controlled Trials.
Foot Ulcer
Cost-effectiveness of clostridial collagenase ointment on wound closure in patients with diabetic foot ulcers: economic analysis of results from a multicenter, randomized, open-label trial.
Foot Ulcer
Enzymatic Debridement of Chronic Nonischemic Diabetic Foot Ulcers: Results of a Randomized, Controlled Trial.
Foot Ulcer
Erratum to: Cost-effectiveness of clostridial collagenase ointment on wound closure in patients with diabetic foot ulcers: economic analysis of results from a multicenter, randomized, open-label trial.
Foot Ulcer
Health Care Spending in Patients With Stage 3 and Stage 4 Pressure Injuries and Patients With Diabetic Foot Ulcers Treated Early With Clostridial Collagenase Ointment: A Retrospective Data Review.
Gas Gangrene
Ca2+-induced linker transformation leads to a compact and rigid collagen-binding domain of Clostridium histolyticum collagenase.
Giant Cell Tumors
Response to hormones of cells cultured from human giant cell tumors of bone.
Glomerulonephritis
Heterogeneity of antibodies in Goodpasture syndrome reacting with type IV collagen.
Glomerulonephritis
Isolation of the specific glomerular basement membrane antigen involved in Goodpasture syndrome.
Infections
BMP9-induced osteogenetic differentiation and bone formation of muscle-derived stem cells.
Ischemic Stroke
Simultaneous detection and separation of hyperacute intracerebral hemorrhage and cerebral ischemia using amide proton transfer MRI.
Joint Instability
The relation between cartilage damage and osteophyte size in a murine model for osteoarthritis in the knee.
Keratoconus
Increase in type I and type IV collagenolytic activity in primary cultures of keratoconus cornea.
Leiomyoma
Extracellular matrix and Hippo signaling as therapeutic targets of antifibrotic compounds for uterine fibroids.
Leiomyoma
Injectable Clostridium histolyticum collagenase as a potential treatment for uterine fibroids.
Leiomyoma
Loss of stiffness in collagen-rich uterine fibroids after digestion with purified collagenase Clostridium histolyticum.
Leiomyoma
Using rheology to quantify the effects of localized collagenase treatments on uterine fibroid digestion.
Leukemia
Mutations that abrogate transactivational activity of the feline leukemia virus long terminal repeat do not affect virus replication.
Leukemia, Feline
Mutations that abrogate transactivational activity of the feline leukemia virus long terminal repeat do not affect virus replication.
Liver Cirrhosis
Extracellular matrix-penetrating nanodrill micelles for liver fibrosis therapy.
Liver Diseases
Relationship between serum and hepatic 7S fragments of type IV collagen in chronic liver disease.
Lung Injury
Chorioamnionitis increases matrix metalloproteinase-8 concentrations in bronchoalveolar lavage fluid from preterm babies.
Lung Neoplasms
[New direct assay method of type IV collagenase in tissue homogenate and biochemical role of collagenase against type I, and IV collagens to the invasion of the stomach and lung cancer]
Lymphatic Metastasis
[Study of type I and IV collagenase activity in human thyroid diseases]
Melanoma
A matrix metalloproteinase-1/protease activated receptor-1 signaling axis promotes melanoma invasion and metastasis.
Melanoma
Suppression of basement membrane type IV collagen degradation and cell invasion in human melanoma cells expressing an antisense RNA for MMP-1.
Melanoma
Suppression of type I collagenase expression by antisense RNA in melanoma cells results in reduced synthesis of the urokinase-type plasminogen activator receptor.
Muscle Spasticity
Intramuscular injection of collagenase clostridium histolyticum may decrease spastic muscle contracture for children with cerebral palsy.
Neoplasm Metastasis
Inhibition of collagenase type I expression by psoralen antisense oligonucleotides in dermal fibroblasts.
Neoplasms
Antitumor promotion and antiinflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone.
Neoplasms
Collagenase-1 injection improved tumor distribution and gene expression of cationic lipoplex.
Neoplasms
Degradation of fibrillar collagen in a human melanoma xenograft improves the efficacy of an oncolytic herpes simplex virus vector.
Neoplasms
Imaging intratumoral convection: pressure-dependent enhancement in chemotherapeutic delivery to solid tumors.
Neoplasms
Inhibition of collagenase type I expression by psoralen antisense oligonucleotides in dermal fibroblasts.
Neoplasms
Phenotypic alterations in fos-transgenic mice correlate with changes in Fos/Jun-dependent collagenase type I expression. Regulation of mouse metalloproteinases by carcinogens, tumor promoters, cAMP, and Fos oncoprotein.
Neoplasms
Profiling, comparison and validation of gene expression in gastric carcinoma and normal stomach.
Neoplasms
Surface modulation of polymeric nanocarriers enhances the stability and delivery of proteins and small molecules.
Neoplasms
Synthesis and collagenase inhibition of new glycosides of aranciamycinone: the aglycon of the naturally occurring antibiotic aranciamycin.
Neoplasms
Targeted disruption of the c-fos gene demonstrates c-fos-dependent and -independent pathways for gene expression stimulated by growth factors or oncogenes.
Neoplasms
Temperature-dependent metastasis of the Lucke renal carcinoma and its significance for studies on mechanisms of metastasis.
Neoplasms
[New direct assay method of type IV collagenase in tissue homogenate and biochemical role of collagenase against type I, and IV collagens to the invasion of the stomach and lung cancer]
Osteoarthritis
Calcitonin gene-related peptide, substance P and GAP-43/B-50 immunoreactivity in the normal and arthrotic knee joint of the mouse.
Osteoarthritis
Glial activation in the collagenase model of nociception associated with osteoarthritis.
Osteoarthritis
Induction of osteoarthritis by intra-articular injection of collagenase in mice. Strain and sex related differences.
Osteoarthritis
The relation between cartilage damage and osteophyte size in a murine model for osteoarthritis in the knee.
Osteoarthritis
[Histopathological study of the effects of intra-articular injection of triamcinolone acetonide on temporomandibular joint osteoarthrosis in goats]
Osteolysis
H-31 human breast cancer cells stimulate type I collagenase production in osteoblast-like cells and induce bone resorption.
Osteosarcoma
Discordant effects of activator protein-1 transcription factor on gene regulation, invasion, and metastasis in spontaneous, radiation-induced, and fos-induced osteosarcomas.
Pancreatic Neoplasms
Heterogeneities of attachment, chemotaxis, and protease production among clones with different metastatic potentials from a human pancreatic cancer cell line.
Penile Induration
"Doc, if it were you, what would you do?": a survey of Men's Health specialists' personal preferences regarding treatment modalities.
Penile Induration
A modified technique for intralesional injection of collagenase Clostridium histolyticum for Peyronie's disease results in reduced procedural morbidity using a standardized hematoma classification rubric.
Penile Induration
A state-of-art review on collagenase Clostridium Histolyticum and Peyronie's disease: drug profile, clinical evidence and safety outcomes.
Penile Induration
Analysis of the clinical safety of intralesional injection of collagenase Clostridium histolyticum (CCH) for adults with Peyronie's disease (PD).
Penile Induration
At what cost is collagenase clostridium histolyticum viable for treating Peyronie's disease in a public healthcare system?
Penile Induration
Baseline characteristics from an ongoing phase 3 study of collagenase clostridium histolyticum in patients with Peyronie's disease.
Penile Induration
Canadian provider perspectives on Collagenase Clostridium histolyticum for the treatment of Peyronie's disease and the impact of its discontinuation.
Penile Induration
Changes in the Effects of Peyronie's Disease After Treatment With Collagenase Clostridium histolyticum: Male Patients and Their Female Partners.
Penile Induration
Characteristics of Men With Peyronie's Disease and Collagenase Clostridium Histolyticum Treatment Failure: Predictors of Surgical Intervention and Outcomes.
Penile Induration
Characteristics predictive of response to collagenase clostridium histolyticum for Peyronie's disease: a review of the literature.
Penile Induration
Clinical Efficacy of Collagenase Clostridium Histolyticum in the Treatment of Peyronie's Disease by Subgroups: Results From Two Large, Double-Blind, Randomized, Placebo-Controlled, Phase 3 Studies.
Penile Induration
Clinical efficacy, safety, and tolerability of collagenase clostridium histolyticum in the treatment of Peyronie's disease from 2 large double-blind, randomized, placebo-controlled phase 3 studies.
Penile Induration
Clinical Experience with Penile Traction Therapy among Men Undergoing Collagenase Clostridium Histolyticum for Peyronie's Disease.
Penile Induration
Clinical safety and effectiveness of collagenase clostridium histolyticum injection in patients with Peyronie's disease: a phase 3 open-label study.
Penile Induration
Collagenase Clostridium histolyticum for the pharmacological management of Peyronie's disease.
Penile Induration
Collagenase Clostridium Histolyticum for the Treatment of Peyronie's Disease: A 'Real World' Clinical Perspective.
Penile Induration
Collagenase clostridium histolyticum for the treatment of Peyronie's disease: a prospective Italian multicentric study.
Penile Induration
Collagenase Clostridium histolyticum for the Treatment of Peyronie's Disease: The Development of This Novel Pharmacologic Approach.
Penile Induration
Collagenase Clostridium histolyticum in the management of Peyronie's disease: a review of the evidence.
Penile Induration
Collagenase Clostridium histolyticum in the treatment of Peyronie's disease: patient selection and perspectives.
Penile Induration
Collagenase Clostridium Histolyticum in the Treatment of Peyronie's Disease: Review of a Minimally Invasive Treatment Option.
Penile Induration
Collagenase clostridium histolyticum intralesional injections for the treatment of Peyronie's disease: a safety profile.
Penile Induration
Collagenase clostridium histolyticum: a novel medical treatment for Peyronie's disease.
Penile Induration
Collagenase Clostridium Histolyticum: A Review in Peyronie's Disease.
Penile Induration
Collagenase versus placebo in the treatment of Peyronie's disease: a double-blind study.
Penile Induration
Comparative Cost-effectiveness of Surgery, Collagenase Clostridium Histolyticum, and Penile Traction Therapy in Men with Peyronie's Disease in an Era of Effective Clinical Treatment.
Penile Induration
Complications and other concerns with intralesional injection therapy with collagenase clostridium histolyticum for Peyronie's disease.
Penile Induration
Conservative management of suspected fractures in men undergoing collagenase clostridium histolyticum for Peyronie's Disease is not associated with worsening of erectile function.
Penile Induration
Continuing Collagenase Clostridium Histolyticum Injections Among Initial Nonresponders Results in Significant Curvature Improvements in the Majority of Peyronie's Disease Men.
Penile Induration
Correction to: Efficacy of Collagenase Clostridium histolyticum (Xiapex®) in Patients with the Acute Phase of Peyronie's Disease.
Penile Induration
Discontinuation from Collagenase Clostridium histolyticum Therapy for Peyronie's Disease: Review and Single-Center Cohort Analysis.
Penile Induration
Editorial Comment: Comparative Cost-effectiveness of Surgery, Collagenase Clostridium Histolyticum, and Penile Traction Therapy in Men with Peyronie's Disease in an Era of Effective Clinical Treatment.
Penile Induration
Editorial Comment: Impact of the advent of collagenase clostridium histolyticum on the surgical management of Peyronie's disease: a population-based analysis.
Penile Induration
Effect of collagenase Clostridium histolyticum on penile vascular and morphological parameters in patients with Peyronie's disease.
Penile Induration
Efficacy and safety of collagenase Clostridium histolyticum in Peyronie's disease following a modified treatment protocol.
Penile Induration
Efficacy of Collagenase Clostridium histolyticum (Xiapex®) in Patients with the Acute Phase of Peyronie's Disease.
Penile Induration
Efficacy of Combined Collagenase Clostridium histolyticum and RestoreX Penile Traction Therapy in Men with Peyronie's Disease.
Penile Induration
Evaluating collagenase Clostridium histolyticum administration protocols in the treatment of Peyronie's disease.
Penile Induration
Expanding the role of injectable collagenase clostridium histolyticum for the treatment of active phase Peyronie's disease.
Penile Induration
Experience in the use of collagenase clostridium histolyticum in the management of Peyronie's disease: current data and future prospects.
Penile Induration
How Atypical Penile Curvature Influence Clinical Outcomes in Patients with Peyronie's Disease Receiving Collagenase Clostridium Histolyticum Therapy?
Penile Induration
Humoral immune responses in Peyronie's disease patients receiving clostridial collagenase therapy.
Penile Induration
Impact of Number of Cycles of Collagenase Clostridium Histolyticum on Outcomes in Patients With Peyronie's Disease.
Penile Induration
Impact of the Advent of Collagenase Clostridium Histolyticum on the Surgical Management of Peyronie's Disease: A Population-Based Analysis.
Penile Induration
Intralesional Collagenase Clostridium Histolyticum Causes Meaningful Improvement in Men with Peyronie's Disease: Results of a Multi-Institutional Analysis.
Penile Induration
Intralesional Injection of Collagenase Clostridium histolyticum May Increase the Risk of Late-Onset Penile Fracture.
Penile Induration
Intralesional Injection of Interferon-?2b Improves Penile Curvature in Men with Peyronie's Disease Independent of Plaque Location.
Penile Induration
Lateral herniation during treatment with collagenase Clostridium histolyticum (Xiaflex) for Peyronie's disease.
Penile Induration
Limited success with clostridium collagenase histolyticum following FDA approval for the treatment of Peyronie's disease.
Penile Induration
Long-term Curvature Deformity Characterization in Men Previously Treated With Collagenase Clostridium Histolyticum for Peyronie's Disease, Subgrouped by Penile Plaque Calcification.
Penile Induration
Long-Term Safety and Curvature Deformity Characterization in Patients Previously Treated with Collagenase Clostridium Histolyticum for Peyronie's Disease.
Penile Induration
Management of Peyronie's disease with collagenase Clostridium histolyticum in the acute phase.
Penile Induration
Managing complications of collagenase Clostridium histolyticum (CCH) injection.
Penile Induration
Multi-institutional Prospective Analysis of Intralesional Injection of Collagenase Clostridium Histolyticum, Tunical Plication, and Partial Plaque Excision and Grafting for the Management of Peyronie's Disease.
Penile Induration
Optimizing collagenase Clostridium histolyticum therapy for Peyronie's disease using a novel approach with percutaneous needle tunnelling.
Penile Induration
Outcomes of Surgery in Peyronie's Disease Following Intralesional Collagenase Clostridium Histolyticum Injections.
Penile Induration
Patient perspectives on Peyronie's disease: results of poststudy interviews from a phase 2 trial of collagenase clostridium histolyticum.
Penile Induration
Patient-reported outcomes from a single-centre prospective post-marketing study on Collagenase Clostridium Histolyticum injections for Peyronie's disease.
Penile Induration
Peyronie's Disease and Injectable Collagenase Clostridium histolyticum: Safety, Efficacy, and Improvements in Subjective Symptoms.
Penile Induration
Phase 2b study of the clinical efficacy and safety of collagenase Clostridium histolyticum in patients with Peyronie disease.
Penile Induration
Plaque Calcification: An Important Predictor of Collagenase Clostridium Histolyticum Treatment Outcomes for Men With Peyronie's Disease.
Penile Induration
Predictive Factors of Patients' and Their Partners' Sexual Function Improvement After Collagenase Clostridium Histolyticum Injection for Peyronie's Disease: Results From a Multi-Center Single-Arm Study.
Penile Induration
Predictors of treatment success after collagenase Clostridium histolyticum injection for Peyronie's disease: development of a nomogram from a multicentre single-arm, non-placebo controlled clinical study.
Penile Induration
Racial variations in response to intralesional collagenase clostridium histolyticum in men with Peyronie's disease.
Penile Induration
Re: Baseline Characteristics from an Ongoing Phase 3 Study of Collagenase Clostridium Histolyticum in Patients with Peyronie's Disease.
Penile Induration
Re: Clinical Efficacy of Collagenase Clostridium histolyticum in the Treatment of Peyronie's Disease by Subgroups: Results from Two Large, Double-blind, Randomized, Placebo-controlled, Phase III Studies.
Penile Induration
Re: clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies.
Penile Induration
Re: clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies: M. Gelbard, I. Goldstein, W. J. Hellstrom, C. G. McMahon, T. Smith, J. Tursi, N. Jones, G. J. Kaufman and C. C. Carson, III J Urol 2013; 190: 199-207.
Penile Induration
Re: Clinical Experience with Penile Traction Therapy among Men Undergoing Collagenase Clostridium histolyticum for Peyronie Disease.
Penile Induration
Re: Clinical Experience with Penile Traction Therapy among Men Undergoing Collagenase Clostridium Histolyticum for Peyronie Disease.
Penile Induration
Re: Impact of the Advent of Collagenase Clostridium Histolyticum on the Surgical Management of Peyronie's Disease: A Population-Based Analysis.
Penile Induration
Re: Multi-Institutional Prospective Analysis of Intralesional Injection of Collagenase Clostridium histolyticum, Tunical Plication, and Partial Plaque Excision and Grafting for the Management of Peyronie's Disease.
Penile Induration
Re: Outcomes of Surgery in Peyronie's Disease following Intralesional Collagenase Clostridium histolyticum Injections.
Penile Induration
Re: Peyronie's Disease and Injectable Collagenase Clostridium histolyticum: Safety, Efficacy, and Improvements in Subjective Symptoms.
Penile Induration
Re: Plaque Calcification: An Important Predictor of Collagenase Clostridium Histolyticum Treatment Outcomes for Men with Peyronie's Disease.
Penile Induration
Re: Plaque Calcification: An Important Predictor of Collagenase Clostridium histolyticum Treatment Outcomes for Men with Peyronie's Disease.
Penile Induration
Re: Results of SMSNA survey regarding complications following intralesional injection therapy with collagenase clostridium histolyticum for Peyronie's disease.
Penile Induration
Re: Safety and Effectiveness of Collagenase Clostridium Histolyticum in the Treatment of Peyronie's Disease Using a New Modified Shortened Protocol.
Penile Induration
Re: Surgical Correction of Persistent Peyronie's Disease following Collagenase Clostridium histolyticum Treatment.
Penile Induration
Restoration of Penile Function and Patient Satisfaction with Intralesional Collagenase Clostridium Histolyticum Injection for Peyronie's Disease.
Penile Induration
Results of SMSNA Survey Regarding Complications Following Intralesional Injection Therapy With Collagenase Clostridium Histolyticum for Peyronie's Disease.
Penile Induration
Results of SMSNA survey regarding complications following intralesional injection therapy with collagenase clostridium histolyticum for Peyronie's disease.
Penile Induration
Review of Intralesional Collagenase Clostridium Histolyticum Injection Therapy and Related Combination Therapies in the Treatment of Peyronie's Disease (an Update).
Penile Induration
Safety and effectiveness of collagenase clostridium histolyticum in the treatment of Peyronie's disease using a new modified shortened protocol.
Penile Induration
Safety and Efficacy of Collagenase Clostridium Histolyticum in Peyronie's Disease Men With Ventral Curvatures.
Penile Induration
Safety and Efficacy of Collagenase Clostridium histolyticum in the Treatment of Acute Phase Peyronie's Disease: A Multi-institutional Analysis.
Penile Induration
Safety and Efficacy of Collagenase Clostridium histolyticum in the Treatment of Acute-Phase Peyronie's Disease.
Penile Induration
Safety and Efficacy Study of Collagenase Clostridium Histolyticum Applied With an Intensive Protocol in the Treatment of Peyronie's Disease.
Penile Induration
Safety of Collagenase Clostridium histolyticum Injection Therapy for Peyronie Disease in Patients Continuing Antiplatelet or Anticoagulant Therapy.
Penile Induration
Safety Profile of Collagenase Clostridium Histolyticum Stratified by Degree of Penile Curvature in Patients With Peyronie Disease.
Penile Induration
Second cycle of intralesional Collagenase Clostridium histolyticum for Peyronie's disease using the modified shortened protocol: Results from a retrospective analysis.
Penile Induration
Self-reported Clinical Meaningfulness Early in the Treatment Course Predicts Objective Outcomes in Men Undergoing Collagenase Clostridium histolyticum Injections for Peyronie Disease.
Penile Induration
Sixty years in the making: collagenase Clostridium histolyticum, from benchtop to FDA approval and beyond.
Penile Induration
Successful Treatment of Residual Curvature in Peyronie's Disease in Men Previously Treated with Intralesional Collagenase Clostridium Histolyticum.
Penile Induration
Surgical correction of persistent Peyronie's disease following collagenase clostridium histolyticum treatment.
Penile Induration
Surgical outcomes after collagenase Clostridium histolyticum failure in patients with Peyronie's disease in a multicenter clinical study.
Penile Induration
Survey of patient and partner satisfaction following collagenase Clostridium histolyticum treatment for Peyronie's disease.
Penile Induration
The 32nd Annual J.P. Morgan Healthcare Conference (January 13-16, 2014 - San Francisco, California, USA): Auxilium Pharmaceuticals.
Penile Induration
The Effects of Collagenase Clostridium histolyticum on Plantar Fibromatosis: A Case Study.
Penile Induration
The Impact of Clostridium Histolyticum Collagenase on the Prevalence and Management of Peyronie's Disease in the United States.
Penile Induration
The Influence of Indentation Deformity on Outcomes With Intralesional Collagenase Clostridium Histolyticum Monotherapy for Peyronie's Disease.
Penile Induration
The Management of Penile Fracture: a Review of the Literature with Special Consideration for Patients Undergoing Collagenase Clostridium Histolyticum Injection Therapy.
Penile Induration
The use of intralesional clostridial collagenase injection therapy for Peyronie's disease: a prospective, single-center, non-placebo-controlled study.
Penile Induration
Treatment of Peyronie's disease via preoperative intralesional collagenase clostridium histolyticum followed by placement of an inflatable penile prosthesis: the new standard of care?
Penile Induration
Treatment of Peyronie's Disease With Collagenase Clostridium histolyticum and Vacuum Therapy: A Randomized, Open-Label Pilot Study.
Penile Induration
Treatment of peyronie's disease with combination of clostridium histolyticum collagenase and penile traction therapy: a prospective, multicenter, single-arm study.
Penile Induration
Treatment Patterns and Healthcare Outcomes with Collagenase Clostridium Histolyticum vs Surgery in Peyronie's Disease: A Retrospective Claims Database Analysis.
Penile Induration
Treatment-related Outcomes for Patients With Atypical Peyronie's Disease Using Xiaflex Injections.
Penile Induration
Variation in collagenase Clostridium histolyticum practice patterns: a Survey of ISSM Members.
Penile Induration
[Collagenase clostridium histolyticum for Peyronie's disease: A new minimally invasive and effective treatment].
Penile Induration
[Efficacy and safety of local injections treatments for Peyronie's disease: Review of the literature].
Periodontitis
Salivary collagenase. Origin, characteristics and relationship to periodontal health.
Placenta, Retained
Equine retained placenta: technique for and tolerance to umbilical artery injections of collagenase.
Polycystic Kidney Diseases
Acceleration of bone formation during fracture healing by poly(Pro-Hyp-Gly)10 and basic fibroblast growth factor containing polycystic kidney disease and collagen-binding domains from Clostridium histolyticum collagenase.
Polycystic Kidney Diseases
Acceleration of callus formation during fracture healing using basic fibroblast growth factor-kidney disease domain-collagen-binding domain fusion protein combined with allogenic demineralized bone powder.
Polycystic Kidney Diseases
Basic Fibroblast Growth Factor Fused with Tandem Collagen-Binding Domains from Clostridium histolyticum Collagenase ColG Increases Bone Formation.
Polycystic Kidney Diseases
Basic Fibroblast Growth Factor-Anchored Multilayered Mesenchymal Cell Sheets Accelerate Periosteal Bone Formation.
Polycystic Kidney Diseases
Effect of Freeze-Dried Allograft Bone with Human Basic Fibroblast Growth Factor Containing a Collagen-Binding Domain from Clostridium Histolyticum Collagenase on Bone Formation after Lumbar Posterolateral Fusion Surgery in Rats.
Polycystic Kidney Diseases
Enhancement of periosteal bone formation by basic fibroblast-derived growth factor containing polycystic kidney disease and collagen-binding domains from Clostridium histolyticum collagenase.
Polycystic Kidney Diseases
Solution structure of clostridial collagenase H and its calcium-dependent global conformation change.
Pressure Ulcer
A retrospective study of the effects of clostridial collagenase ointment and negative pressure wound therapy for the treatment of chronic pressure ulcers.
Pressure Ulcer
Clostridial collagenase ointment and medicinal honey utilization for pressure ulcers in US hospitals.
Pressure Ulcer
Comparative Effectiveness of Clostridial Collagenase Ointment to Medicinal Honey for Treatment of Pressure Ulcers.
Pressure Ulcer
Cost effectiveness of adding clostridial collagenase ointment to selective debridement in individuals with stage IV pressure ulcers.
Pressure Ulcer
Economic analysis and budget impact of clostridial collagenase ointment compared with medicinal honey for treatment of pressure ulcers in the US.
Pressure Ulcer
Treating pressure ulcers with clostridial collagenase ointment: Results from the US Wound Registry.
Pterygium
[Electron-microscopic and biochemical characteristics of pterygia (author's transl)]
Respiratory Distress Syndrome
Chorioamnionitis increases matrix metalloproteinase-8 concentrations in bronchoalveolar lavage fluid from preterm babies.
Retinopathy of Prematurity
Enzyme-assisted vitrectomy with bacterial collagenase. Pilot human studies.
Rhabdomyosarcoma
[5-fluorouracil inhibits bacterial collagenase and the collagenolytic system of a human rhabdomyosarcoma]
Sarcoma
CD4+ T-cells from mice immunized to syngeneic sarcomas recognize distinct, non-shared tumor antigens.
Sarcoma, Yoshida
Synthesis and collagenase inhibition of new glycosides of aranciamycinone: the aglycon of the naturally occurring antibiotic aranciamycin.
Skin Neoplasms
Inhibition of collagenase type I expression by psoralen antisense oligonucleotides in dermal fibroblasts.
Stomach Neoplasms
[New direct assay method of type IV collagenase in tissue homogenate and biochemical role of collagenase against type I, and IV collagens to the invasion of the stomach and lung cancer]
Stroke
Effects of selective hypothermia on blood-brain barrier integrity and tight junction protein expression levels after intracerebral hemorrhage in rats.
Synovitis
Decrease in expression of bone morphogenetic proteins 4 and 5 in synovial tissue of patients with osteoarthritis and rheumatoid arthritis.
Tendinopathy
Adipose micro-grafts enhance tendinopathy healing in ovine model: An in vivo experimental perspective study.
Tendinopathy
Autologous tenocyte therapy for experimental achilles tendinopathy in a rabbit model.
Tendinopathy
Histopathological study of the infrapatellar fat pad in the rat model of patellar tendinopathy: A basic study.
Tendinopathy
Pulsed electromagnetic fields improve the healing process of Achilles tendinopathy: a pilot study in a rat model.
Tendinopathy
The Healing Potential of Plantago lanceolata Ointment on Collagenase-Induced Tendinitis in Burros (Equus asinus)
Tetanus
Inhibition of bacterial carbonic anhydrases and zinc proteases: from orphan targets to innovative new antibiotic drugs.
Tetanus
Inhibition of collagenase breakdown of equine corneas by tetanus antitoxin, equine serum and acetylcysteine.
Urethral Stricture
Collagenase Clostridium histolyticum (Xiaflex) for the Treatment of Urethral Stricture Disease in a Rat Model of Urethral Fibrosis.
Urethral Stricture
Collagenase Clostridium Histolyticum in the Treatment of Urologic Disease: Current and Future Impact.
Urologic Diseases
Collagenase Clostridium Histolyticum in the Treatment of Urologic Disease: Current and Future Impact.
Vitreoretinopathy, Proliferative
Enzyme-assisted vitrectomy with bacterial collagenase. Pilot human studies.
html completed